Good MorningEquities started Wednesday on solid footing rising more than 1.0% ahead of the FOMC meeting. The weaker-than-expected CPI gave the market some hope the Fed would give some relief and those hopes were dashed. While the Fed hiked rates by only 50 basis points the new statement indicated the peak of interest rates will likely be over 5.0% and remain at that level into 2023. This news caused the market to reverse course and the S&P 500 shed 0.60% at the close of the session.
The next hurdle for the market is the PCE price index which comes out next Friday. If the index confirms a downtrend in the pace of inflation it could send the market soaring and usher in the Santa Claus Rally. If not, the market could be in for a rough holiday as traders and investors begin to position for what could be a very bad year for stocks. Featured: The single best 10% yield in the market? (The Oxford Club) 
|
Markets | | |
Enterprise Products Partners (NYSE: EPD) has recently been on a wild ride. It has gone thru some stunning peaks and troughs and ended up 7.82% year to date. As a result, investors might wonder if its current stock price represents a good entry for buying shares.
So let's examine the bull and... Read the Full Story |
|
|
Stocks | | |
U.S. mid-cap stocks are on pace to outperform their large-cap peers for the second straight year. The S&P 400 is down 13% year-to-date, a roughly 400 basis points edge over the S&P 500.
Mid-cap land has long been regarded as the ‘sweet spot’ for equity investors. Companies are... Read the Full Story |
|
Stocks | | | A bumpy day of trading on Wall Street ended with stocks broadly lower Wednesday after the Federal Reserve raised its benchmark interest rate in its fight against inflation and signaled that more hikes lay ahead.
As expected, the central bank raised its key short-term rate by 0.50 per... Read the Full Story |
|
From Our PartnersBecause of a rare situation unlike anything we've ever seen, Wall Street is now projecting a massive rise for this stock over the next 18 months. The consensus analyst price targets for the $30 stock are now up to $280. How is that possible? Well, when you see what this company actually does, you will understand. | | | | Watch this video for the full explanation of this business. |
|
Markets | | |
Latin American e-commerce specialist MercadoLibre Inc. (NASDAQ: MELI) has only trended lower in 2022, and a new partnership could boost the stock.
Earlier this month, the chief financial officer of the Argentina-based company told Reuters that MercadoLibre would begin processing busines... Read the Full Story |
|
Markets | | | Japan's trade deficit surged to over 2 trillion yen ($15 billion) in November as higher costs for oil and a weak yen combined to push imports sharply higher.
It was the 16th straight month of red ink and a record high for the month of November. The country will likely post a record d... Read the Full Story |
|
From Our PartnersImagine being able to outperform the market by 6X every single year.
Now imagine accomplishing that, without spending a lick of time studying charts, or doing any kind of stock market analysis.
Sounds like a pipe dream, right?
Yet hundreds of investors have been using a little-known strategy to collect annual stock market gains of 63% over the last 3 years – without doing any real work…
And you can, too. | | | | Click here to discover how. |
|
Markets | | |
REV Group (NYSE: REVG) has been struggling with supply chain issues and economic woe just like everybody else but now the stock is ready to make a major reversal. The company’s Q4 results and guidance for the year were better than expected and supported by the company’s diverse operati... Read the Full Story |
|
Markets | | | Shares skidded in Europe and Asia on Thursday after a retreat on Wall Street by investors dismayed over the Federal Reserve’s warning that still more interest rate hikes are in store following its latest increase.
Oil prices fell and U.S. futures also dropped.
The dec... Read the Full Story |
|
Politics | | | Britain's central bank is expected to deliver its ninth straight interest rate hike Thursday, though it will likely be smaller than last month's outsized increase as inflation shows signs of easing.
Most economists expect the Bank of England to raise its key interest rate by half a p... Read the Full Story |
|
Markets | | | Ten years after receiving it, New York University made public a $100 million gift from the hedge fund leader John Paulson, who made a fortune in the U.S. housing crisis, to support the construction of a now mostly-complete building that will also be named after him.
The donation anno... Read the Full Story |
|
Markets | | |
Updated - December 14, 2022– via InvestorWire – Mullen Automotive, Inc., an emerging electric vehicle (“EV”) manufacturer, announces today that it has entered into a definitive agreement with Loop Global Inc. ("Loop"), a full-service EV charging solution provider, to build ... Read the Full Story |
|
Thursday's Early Bird Stock Of The Day Freeline Therapeutics Holdings plc, a clinical-stage biotechnology company, develops transformative adeno-associated virus (AAV) vector-mediated gene therapies. It develops FLT180a for the treatment of hemophilia B.; FLT201 for the treatment of Type 1 Gaucher disease; and FLT190 for the treatment of Fabry disease. in addition, it has research programs for systemic gene therapy. The company was founded in 2015 and is headquartered in Stevenage, the United Kingdom. | | View Today's Stock Pick |
|
